Stay updated with breaking news from Ipca Labs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
With its 100 billionaires, Beijing has more than any other city in the world It over-took New York City - with 99 - in this year's Forbes' World's Billionaire List China's capital added 33 new billionaires in the last year, despite the pandemic China was the only major world economy to grow at all last year amid Covid-19 The richest person in Beijing was Zhang Yiming, the founder of the app TikTok
ChrysCapital announces investment in Corona Remedies By IANS | Published on Mon, Apr 5 2021 20:57 IST | 9 Views CFMA sees poetic justice for MF investors through 6 FTMF shut funds case in SC.. Image Source: IANS News New Delhi, April 5 : ChrysCapital, one of the leading private equity funds in India, has announced its investment in Corona Remedies Private Limited (Corona), one of the country's fastest growing pharmaceutical companies, by acquiring a 27 per cent stake through an entirely secondary deal. Commenting on the investment, Kshitij Sheth, Director, ChrysCapital, sa...
Ipca Labs on strong growth path: Why this pharma company is stock pick of the week The stock pick of the week, IPCA Labs Synopsis Ipca with its vertical integration, cost advantage and strong export business has been able to manage good set of numbers. Having a strong balance sheet with low debt/equity ratio despite being in an investment phase is another positive for this counter which has made it a favourite of analysts. Ipca Labs, a mid-sized pharma company continues to report good numbers and its results for the third quarter of 2020-21 were no different. The y-o-y growth on its consolida...
Here are a few stocks which may buzz the most in today's trade.
Explore Now NEW DELHI: Drug firm Ipca Laboratories on Thursday reported a 35.44 per cent rise in consolidated net profit to Rs 267.56 crore for the third quarter ended December 2020, on the back of robust sales in domestic and international markets. The company had posted a net profit of Rs 197.54 crore for the same period of the previous fiscal, Ipca Labs said in a BSE filing. Its consolidated total income stood at Rs 1,425.21 crore for the quarter under consideration. It was Rs 1,230.99 crore for in the year-ago period, it added. Indian formulations income was up 8 per cent at Rs 523.16 c...